Octagon Capital Advisors LP - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 156 filers reported holding ITEOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
Octagon Capital Advisors LP ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,116,900
-85.8%
102,000
-82.9%
0.17%
-84.3%
Q2 2023$7,891,040
-2.7%
596,0000.0%1.10%
-5.9%
Q1 2023$8,111,560
-6.7%
596,000
+33.9%
1.17%
-13.7%
Q4 2022$8,690,850
-40.1%
445,000
-1.3%
1.35%
-56.9%
Q1 2022$14,506,000
-30.9%
450,7760.0%3.14%
-23.2%
Q4 2021$20,988,000450,7764.08%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders